Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine + Sufentanil for CRBD Prevention in Prostatectomy
NCT05957653Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Oct 2023
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of lidocaine, sufentanil in cystitis, sponsored by Renji Hospital. Status: unknown.
02
Drugs
lidocainesufentanil
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT05957653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05957653.